title: Global cardiovascular risk assessment in the management of primary hypertension: the role of the kidney.
abstract: The knowledge of each patient's global risk profile is a prerequisite for effective therapeutic strategies in primary hypertension. Detecting the presence of subclinical organ damage at the cardiac, vascular, and renal levels is key for stratifying cardiovascular risk and may also be helpful in choosing antihypertensive agents and in monitoring the effectiveness of treatment. A systematic, in-depth search for subclinical organ damage, however, may be difficult to carry out because of logistic and economic problems related to the high prevalence of hypertension in the population. Renal abnormalities such as microalbuminuria and reduction in glomerular filtration rate have proven to be powerful predictors of cardiovascular and renal outcome. Thanks to their relatively low cost and wide applicability, more widespread use of these tests in the diagnostic workup will help detect subsets of patients at greater risk for whom additional preventive and therapeutic treatment is advisable.
authors: Università Degli Studi e I.R.C.C.S. Azienda Ospedaliera Universitaria San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, 16125 Genoa, Italy.
authors: Francesca
authors: F
authors: Viazzi
authors: Giovanna
authors: G
authors: Leoncini
authors: Roberto
authors: R
authors: Pontremoli
references: J Hypertens. 2010 Nov;28(11):2204-9
references: 20616753
references: N Engl J Med. 2004 Sep 23;351(13):1296-305
references: 15385656
references: Nephrol Dial Transplant. 1998 Mar;13(3):564-9
references: 9550628
references: Lancet. 2002 Mar 23;359(9311):995-1003
references: 11937178
references: J Hypertens. 2002 Jul;20(7):1315-21
references: 12131528
references: Circulation. 1993 Oct;88(4 Pt 1):1444-55
references: 8403291
references: J Hypertens. 2008 Mar;26(3):427-32
references: 18300851
references: J Hypertens. 1999 Jul;17(7):993-1000
references: 10419073
references: Hypertension. 2000 Apr;35(4):898-903
references: 10775558
references: Lancet. 2003 Nov 8;362(9395):1527-35
references: 14615107
references: Nephrol Dial Transplant. 1996 Nov;11(11):2113-5
references: 8941561
references: Hypertension. 2000 Feb;35(2):539-43
references: 10679494
references: Lancet. 2010 Jun 12;375(9731):2073-81
references: 20483451
references: JAMA. 1996 Sep 11;276(10):785-91
references: 8769587
references: J Am Soc Nephrol. 2011 Jul;22(7):1353-64
references: 21719791
references: J Hypertens. 2013 Jul;31(7):1281-357
references: 23817082
references: N Engl J Med. 1999 Jan 7;340(1):14-22
references: 9878640
references: Ann Intern Med. 2003 Dec 2;139(11):901-6
references: 14644892
references: J Hum Hypertens. 2002 Aug;16(8):591-5
references: 12149666
references: Circulation. 1998 Jan 6-13;97(1):48-54
references: 9443431
references: J Am Coll Cardiol. 1998 Jun;31(7):1635-40
references: 9626845
references: Ann Intern Med. 2003 Jul 15;139(2):137-47
references: 12859163
references: J Hypertens. 2010 Apr;28(4):848-55
references: 20087212
references: Lancet. 2002 Nov 2;360(9343):1347-60
references: 12423980
references: Circulation. 2002 Nov 5;106(19):2422-7
references: 12417537
references: Hypertension. 2005 Feb;45(2):198-202
references: 15655123
references: J Hypertens. 1998 Nov;16(11):1667-76
references: 9856368
references: J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S89-91
references: 15938043
references: Circulation. 2001 Jun 19;103(24):2949-54
references: 11413085